nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisuride—DRD5—eyelid—leprosy	0.171	0.192	CbGeAlD
Lisuride—HTR1B—trigeminal nerve—leprosy	0.0773	0.0868	CbGeAlD
Lisuride—HTR1D—trigeminal nerve—leprosy	0.0748	0.084	CbGeAlD
Lisuride—HTR1B—cranial nerve—leprosy	0.0551	0.0618	CbGeAlD
Lisuride—HTR1D—cranial nerve—leprosy	0.0533	0.0599	CbGeAlD
Lisuride—HTR2A—trigeminal nerve—leprosy	0.0372	0.0417	CbGeAlD
Lisuride—DRD1—nerve—leprosy	0.0348	0.0391	CbGeAlD
Lisuride—HTR2A—cranial nerve—leprosy	0.0265	0.0297	CbGeAlD
Lisuride—HTR2A—hindlimb—leprosy	0.0223	0.0251	CbGeAlD
Lisuride—HTR1B—blood vessel—leprosy	0.0222	0.0249	CbGeAlD
Lisuride—HTR1D—blood vessel—leprosy	0.0215	0.0241	CbGeAlD
Lisuride—DRD2—nerve—leprosy	0.0206	0.0231	CbGeAlD
Lisuride—ADRA2A—peripheral nervous system—leprosy	0.0205	0.023	CbGeAlD
Lisuride—HTR2A—appendage—leprosy	0.0191	0.0215	CbGeAlD
Lisuride—HTR2A—peripheral nervous system—leprosy	0.0174	0.0195	CbGeAlD
Lisuride—DRD4—testis—leprosy	0.0159	0.0178	CbGeAlD
Lisuride—HTR2A—nerve—leprosy	0.0136	0.0152	CbGeAlD
Lisuride—HTR1D—eye—leprosy	0.0114	0.0128	CbGeAlD
Lisuride—DRD3—nervous system—leprosy	0.0109	0.0123	CbGeAlD
Lisuride—Dementia—Thalidomide—leprosy	0.0109	0.0995	CcSEcCtD
Lisuride—HTR2A—blood vessel—leprosy	0.0107	0.012	CbGeAlD
Lisuride—Pericarditis—Thalidomide—leprosy	0.0103	0.0944	CcSEcCtD
Lisuride—DRD5—nervous system—leprosy	0.0103	0.0115	CbGeAlD
Lisuride—HTR2B—skin of body—leprosy	0.00924	0.0104	CbGeAlD
Lisuride—DRD2—eye—leprosy	0.0086	0.00966	CbGeAlD
Lisuride—ADRA1B—nervous system—leprosy	0.0084	0.00944	CbGeAlD
Lisuride—ADRA1D—nervous system—leprosy	0.00822	0.00923	CbGeAlD
Lisuride—DRD1—nervous system—leprosy	0.00783	0.0088	CbGeAlD
Lisuride—HTR2B—tendon—leprosy	0.00703	0.0079	CbGeAlD
Lisuride—HTR1B—nervous system—leprosy	0.00635	0.00713	CbGeAlD
Lisuride—HTR1D—nervous system—leprosy	0.00615	0.0069	CbGeAlD
Lisuride—HTR2C—nervous system—leprosy	0.00609	0.00683	CbGeAlD
Lisuride—ADRB1—nervous system—leprosy	0.00597	0.0067	CbGeAlD
Lisuride—Pleural effusion—Thalidomide—leprosy	0.00583	0.0533	CcSEcCtD
Lisuride—HTR2B—nervous system—leprosy	0.00572	0.00642	CbGeAlD
Lisuride—HTR2A—eye—leprosy	0.00567	0.00637	CbGeAlD
Lisuride—ADRA2C—tendon—leprosy	0.00554	0.00622	CbGeAlD
Lisuride—HTR1A—nervous system—leprosy	0.00512	0.00575	CbGeAlD
Lisuride—DRD2—testis—leprosy	0.00472	0.00529	CbGeAlD
Lisuride—DRD2—nervous system—leprosy	0.00463	0.0052	CbGeAlD
Lisuride—ADRA2C—testis—leprosy	0.00458	0.00515	CbGeAlD
Lisuride—ADRA2C—nervous system—leprosy	0.0045	0.00505	CbGeAlD
Lisuride—ADRA2A—tendon—leprosy	0.00442	0.00496	CbGeAlD
Lisuride—HTR2A—tendon—leprosy	0.00376	0.00422	CbGeAlD
Lisuride—ADRA2A—testis—leprosy	0.00366	0.00411	CbGeAlD
Lisuride—ADRA2A—nervous system—leprosy	0.00359	0.00403	CbGeAlD
Lisuride—Vertigo—Dapsone—leprosy	0.00342	0.0313	CcSEcCtD
Lisuride—Cough—Dapsone—leprosy	0.00332	0.0304	CcSEcCtD
Lisuride—Disturbance in sexual arousal—Thalidomide—leprosy	0.00321	0.0294	CcSEcCtD
Lisuride—HTR2A—testis—leprosy	0.00311	0.00349	CbGeAlD
Lisuride—HTR2A—nervous system—leprosy	0.00305	0.00343	CbGeAlD
Lisuride—Tachycardia—Dapsone—leprosy	0.00303	0.0278	CcSEcCtD
Lisuride—Dehydration—Thalidomide—leprosy	0.00301	0.0276	CcSEcCtD
Lisuride—Orthostatic hypotension—Thalidomide—leprosy	0.00296	0.0271	CcSEcCtD
Lisuride—CYP2D6—testis—leprosy	0.00283	0.00318	CbGeAlD
Lisuride—CYP3A4—nervous system—leprosy	0.00283	0.00317	CbGeAlD
Lisuride—Insomnia—Dapsone—leprosy	0.00281	0.0257	CcSEcCtD
Lisuride—CYP2D6—nervous system—leprosy	0.00278	0.00312	CbGeAlD
Lisuride—Weight increased—Thalidomide—leprosy	0.00255	0.0233	CcSEcCtD
Lisuride—Weight decreased—Thalidomide—leprosy	0.00253	0.0232	CcSEcCtD
Lisuride—Sweating—Thalidomide—leprosy	0.00239	0.0219	CcSEcCtD
Lisuride—Oedema peripheral—Thalidomide—leprosy	0.00221	0.0202	CcSEcCtD
Lisuride—Cardiac disorder—Thalidomide—leprosy	0.00208	0.019	CcSEcCtD
Lisuride—Angiopathy—Thalidomide—leprosy	0.00203	0.0186	CcSEcCtD
Lisuride—Immune system disorder—Thalidomide—leprosy	0.00202	0.0185	CcSEcCtD
Lisuride—Mediastinal disorder—Thalidomide—leprosy	0.00202	0.0185	CcSEcCtD
Lisuride—Vomiting—Dapsone—leprosy	0.00198	0.0181	CcSEcCtD
Lisuride—Mental disorder—Thalidomide—leprosy	0.00196	0.018	CcSEcCtD
Lisuride—Malnutrition—Thalidomide—leprosy	0.00195	0.0178	CcSEcCtD
Lisuride—Headache—Dapsone—leprosy	0.00195	0.0178	CcSEcCtD
Lisuride—Vertigo—Thalidomide—leprosy	0.00175	0.016	CcSEcCtD
Lisuride—Syncope—Thalidomide—leprosy	0.00175	0.016	CcSEcCtD
Lisuride—Palpitations—Thalidomide—leprosy	0.00172	0.0158	CcSEcCtD
Lisuride—Cough—Thalidomide—leprosy	0.0017	0.0156	CcSEcCtD
Lisuride—Anxiety—Thalidomide—leprosy	0.00165	0.0151	CcSEcCtD
Lisuride—Dry mouth—Thalidomide—leprosy	0.00162	0.0149	CcSEcCtD
Lisuride—Confusional state—Thalidomide—leprosy	0.0016	0.0147	CcSEcCtD
Lisuride—Infection—Thalidomide—leprosy	0.00158	0.0145	CcSEcCtD
Lisuride—Nervous system disorder—Thalidomide—leprosy	0.00156	0.0143	CcSEcCtD
Lisuride—Tachycardia—Thalidomide—leprosy	0.00155	0.0142	CcSEcCtD
Lisuride—Hyperhidrosis—Thalidomide—leprosy	0.00154	0.0141	CcSEcCtD
Lisuride—Anorexia—Thalidomide—leprosy	0.00152	0.0139	CcSEcCtD
Lisuride—Insomnia—Thalidomide—leprosy	0.00144	0.0132	CcSEcCtD
Lisuride—Dyspnoea—Thalidomide—leprosy	0.00142	0.013	CcSEcCtD
Lisuride—Somnolence—Thalidomide—leprosy	0.00141	0.0129	CcSEcCtD
Lisuride—Decreased appetite—Thalidomide—leprosy	0.00138	0.0127	CcSEcCtD
Lisuride—Gastrointestinal disorder—Thalidomide—leprosy	0.00137	0.0126	CcSEcCtD
Lisuride—Fatigue—Thalidomide—leprosy	0.00137	0.0126	CcSEcCtD
Lisuride—Constipation—Thalidomide—leprosy	0.00136	0.0125	CcSEcCtD
Lisuride—Feeling abnormal—Thalidomide—leprosy	0.00131	0.012	CcSEcCtD
Lisuride—Asthenia—Thalidomide—leprosy	0.00114	0.0104	CcSEcCtD
Lisuride—Dizziness—Thalidomide—leprosy	0.00105	0.00963	CcSEcCtD
Lisuride—Vomiting—Thalidomide—leprosy	0.00101	0.00926	CcSEcCtD
Lisuride—Headache—Thalidomide—leprosy	0.000997	0.00912	CcSEcCtD
